Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)

Abroad (travel likely)Recruiting

Conditions

Tricuspid Valve Regurgitation · Heart Valve Diseases · Cardiovascular Diseases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Herz-und Diabeteszentrum NRW, Bad Oeynhausen, Germany
Contact: Study coordinator (Volker Rudolph, Prof. MD) · vrudolph@hdz-nrw.de
Inselspital, Bern, Switzerland
Contact: Study coordinator (Fabien Praz, Prof. MD) · fabien.praz@insel.ch

Study leads

Volker Rudolph, Prof. MD
Principal Investigator
Herz-und Diabeteszentrum NRW, Bad Oeynhausen
Fabien Praz, Prof. MD
Principal Investigator
Bern, Insespital, Switzerland

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The TRICURE EU Pivotal Study

Tricuspid Valve Regurgitation · Heart Valve Disease · Cardiovascular Diseases

Abroad (travel likely)Recruiting

Aalst, Belgium · Antwerp, Belgium

Robotic Transjugular Transcatheter Tricuspid Valve Replacement

Tricuspid Regurgitation (TR) · Valvular Heart Diseases · Transcatheter Valve Replacement

Abroad (travel likely)Recruiting

Shatin, Hong Kong

Trisol System EFS Study

Tricuspid Regurgitation

Abroad (travel likely)Recruiting

Los Angeles, United States · Atlanta, United States

Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation

Tricuspid Regurgitation · Tricuspid Valve Disease · Tricuspid Valvular Disorders

Abroad (travel likely)Recruiting

Sydney, Australia · Adelaide, Australia